Is Ozempic or Mounjaro on the PBS in Australia? (2026 Update)

Yes, with conditions. Ozempic (semaglutide) and Mounjaro (tirzepatide) are both PBS-listed in Australia, but only for type 2 diabetes. If you want either drug for weight management, you need a private prescription, which runs $300-500 per month depending on the dose and brand. Here is the full breakdown for 2026.

PBS Coverage at a Glance

PBS copayments are 2026 figures. Prices vary by pharmacy and dose.

Ozempic PBS Eligibility in Australia

Ozempic is PBS-subsidised for adults with type 2 diabetes when:

• You have a confirmed type 2 diabetes diagnosis.
• You have tried metformin first (unless contraindicated).
• Your HbA1c remains above target on existing therapy.
• Prescribed by a GP or endocrinologist.

Ozempic is not PBS-covered for weight loss or obesity management without type 2 diabetes. If your only indication is weight management, you need a private prescription.

The PBS-subsidised dose is typically 0.5mg or 1mg weekly. The 2mg dose for better glycaemic control may require authority prescription in some cases.

Mounjaro (Tirzepatide) PBS Status

Mounjaro received TGA approval in Australia for both type 2 diabetes and weight management. For PBS subsidy, the same principle applies: PBS listing covers the type 2 diabetes indication only.

For obesity or weight management without a diabetes diagnosis, Mounjaro requires a private prescription. Private monthly costs typically range $350-500 depending on dose and pharmacy.

Mounjaro is the first dual GIP/GLP-1 receptor agonist available in Australia. Clinical trials showed greater average weight loss than semaglutide at equivalent stages, which has made it popular for private weight management protocols.

Wegovy in Australia 2026

Ready to track your protocol?

• Smart reminders so you never miss a dose
• Progress tracking with photos and weight
• Medication level curves for every compound

Get Regimen Free

Wegovy (semaglutide 2.4mg) is TGA-approved in Australia for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition (verify current TGA indication at tga.gov.au). However, as of 2026 it remains on a limited supply list in Australia due to ongoing global manufacturing constraints.

PBS listing for Wegovy for obesity has not been finalised as of mid-2026 (verify current PBS status at pbs.gov.au). Most patients who qualify access it via private prescription while they wait for wider availability.

Private Prescription Costs: What to Expect

If you do not have type 2 diabetes and want to use Ozempic or Mounjaro for weight management, you are paying out of pocket. Here is a realistic cost breakdown:

Ozempic (semaglutide) private script

• 0.25-0.5mg starter dose: ~$150-200/month
• 1mg maintenance dose: ~$300-380/month
• Sourced from a private GP or weight management clinic

Mounjaro (tirzepatide) private script

• 2.5mg starter dose: ~$200-280/month
• 5-10mg maintenance dose: ~$380-500/month

These prices vary by pharmacy and whether the clinic bundles the consultation into the cost. Most private weight management clinics in Australia charge a monthly fee that includes the consultation and prescription, typically $250-500/month all-in at the 1mg+ dose range.

How to Get a GLP-1 Prescription in Australia

For type 2 diabetes (PBS-covered)

1. See your GP with a confirmed T2DM diagnosis and recent HbA1c result.
2. Your GP confirms you have tried first-line options (typically metformin).
3. Ozempic or Mounjaro is prescribed on the PBS.
4. Fill at any pharmacy and pay the standard PBS copayment.

For weight management (private prescription)

1. Book a telehealth appointment or in-person visit with a GP or weight management clinic.
2. Discuss your BMI, weight history, and any related conditions.
3. If eligible, the doctor issues a private prescription.
4. Fill at a pharmacy and pay full private price, no PBS subsidy.

Some telehealth platforms offer monthly subscriptions that include the consultation, prescription renewal, and support. This can simplify the process but tends to cost more upfront.

Can You Get Compounded GLP-1 in Australia?

Unlike the United States, Australia has much stricter rules around compounded GLP-1 medications. The TGA does not permit compounding of tirzepatide or semaglutide while brand-name equivalents are commercially available, with limited exceptions.

If you see a clinic or pharmacy offering compounded semaglutide or tirzepatide in Australia at a significantly lower price, check their authorisations carefully. Most legitimate Australian providers supply TGA-approved Ozempic or Mounjaro brand products, not compounded alternatives.

Tracking Your GLP-1 Protocol

Ozempic and Mounjaro are weekly injections with a titration schedule, where doses increase every 4 weeks. Tracking your injections, doses, side effects, and weight trends in one place makes it much easier to report back to your prescriber and see whether you are on the right titration timeline.

Regimen supports Ozempic, Mounjaro, and Wegovy tracking with dose reminders, titration calendars, blood level modelling, and Apple Health / Google Health Connect integration.